Specialty Ophthalmology
-
Featured
Mass Eye and Ear Ophthalmology: Celebrating 200 Years of Excellence in Patient Care, Research, and Education
This year, Mass Eye and Ear is celebrating its 200th anniversary. To kick things off, we are highlighting some of the ophthalmology department’s most significant achievements in patient care, research, and education.
-
Featured
Cell Therapy That Repairs Cornea Damage With Patient's Own Stem Cells Achieves Positive Phase I Trial Results
Cultivated autologous limbal epithelial cells (CALEC) procedure shown to be safe and feasible with early positive results of restored cornea surfaces or vision gains in four patients with severe chemical burns.
-
Featured
Finding Treatment Targets for Age-related Macular Degeneration
Mass Eye and Ear clinician scientists have been behind some of the biggest breakthroughs in treating age-related macular degeneration (AMD), but they believe more work needs to be done. They are looking at new ways to detect, classify, and treat the blinding disease earlier.
-
Mass Eye and Ear Sets Standards of Transparency and Accountability in Ophthalmology
The Department of Ophthalmology at Massachusetts Eye and Ear/Massachusetts General Hospital leads the ophthalmology community in developing and implementing outcome measures in every subspecialty area—setting the standard for transparency, accountability, and continued quality improvement in the field.
-
Non-invasive OCTA Imaging Biomarker Tied to Neovascular Glaucoma in Patients With Proliferative Diabetic Retinopathy
John B. Miller, MD, Edward S. Lu, MD, and colleagues found retinal ischemia on widefield swept-source optical coherence tomography angiography was associated with 13-fold increased odds of neovascular glaucoma, a vision-threatening complication in patients with proliferative diabetic retinopathy.
-
Compassionomics: The Science and Practice of Caring
Inês Laíns, MD, PhD, and colleagues summarize the robust scientific evidence that compassion can measurably improve patient outcomes and the well-being of healthcare providers. They outline strategies for measuring compassion, and to train and cultivate compassionate care.
Ophthalmology Contributors
-
Alice C. Lorch, MD, MPH
Assistant Professor of Ophthalmology, Harvard Medical School, Associate Chief for Quality for the Department of Ophthalmology, Mass Eye and Ear, Director, Harvard Ophthalmology Residency Training Program
Recent Article
Usage Patterns of Minimally Invasive Glaucoma Surgery Differ by Glaucoma Type
-
Bruce Ksander, PhD
Associate Professor of Ophthalmology, Harvard Medical School, Associate Scientist, Mass Eye and Ear
Recent Article
Turning Back the Clock on Aged Eye Cells
-
Janey L. Wiggs, MD, PhD
Associate Chief, Ophthalmology Clinical Research, Mass Eye and Ear, Paul Austin Chandler Professor of Ophthalmology, Harvard Medical School
Recent Article
Genetic Risk Factor for Alzheimer's Disease Linked to Reduced Glaucoma Risk
-
Joan W. Miller, MD
Chief, Ophthalmology Department, Massachusetts General Hospital, Chief, Ophthalmology Department, Mass Eye and Ear, Ophthalmologist-in-Chief, Brigham and Women’s Hospital
Recent Article
Mass Eye and Ear Sets Standards of Transparency and Accountability in Ophthalmology
-
John B. Miller, MD
Clinician–Investigator, Yeatts Retina Research Laboratory, Mass Eye and Ear, Member, Diabetic Eye Disease Center of Excellence, Assistant Professor of Ophthalmology, Harvard Medical School
Recent Article
Non-invasive OCTA Imaging Biomarker Tied to Neovascular Glaucoma in Patients With Proliferative Diabetic Retinopathy
-
Lucia Sobrin, MD, MPH
Associate Chief of Clinical Data Science and Director of the Morse Laser Center, Mass Eye and Ear, Associate Professor of Ophthalmology, Harvard Medical School, Co-Director, Ocular Immunology and Uveitis Fellowship
Recent Article
Younger Age, Albuminuria Linked to Advanced Diabetic Retinopathy in South India
-
Luk Vandenberghe, PhD
Associate Professor of Ophthalmology, Harvard Medical School, Grousbeck Family Chair in Gene Therapy and Director of the Grousbeck Gene Therapy Center, Mass Eye and Ear
Recent Article
Developing a Gene-based Vaccine Candidate for COVID-19
-
Meredith Gregory-Ksander, PhD
Associate Scientist, Schepens Eye Research Institute, Mass Eye and Ear, Assistant Professor of Ophthalmology, Harvard Medical School
Recent Article
Turning Back the Clock on Aged Eye Cells
-
Milica Margeta, MD, PhD
Assistant Professor of Ophthalmology, Harvard Medical School, Assistant Scientist, Mass Eye and Ear
Recent Article
Genetic Risk Factor for Alzheimer's Disease Linked to Reduced Glaucoma Risk
-
Nazlee Zebardast, MD, MSc
Director, Glaucoma Imaging, Mass Eye and Ear/Massachusetts General Hospital Department of Ophthalmology, Assistant Professor, Ophthalmology, Harvard Medical School
Recent Article
Usage Patterns of Minimally Invasive Glaucoma Surgery Differ by Glaucoma Type
-
Tobias Elze, PhD
Assistant Professor of Ophthalmology, Harvard Medical School, Assistant Scientist, Mass Eye and Ear
Recent Article
Usage Patterns of Minimally Invasive Glaucoma Surgery Differ by Glaucoma Type
-
Ula V. Jurkunas, MD
Associate Director, Cornea Service, Mass Eye and Ear, Associate Professor of Ophthalmology, Harvard Medical School
Recent Article
The Neuropeptide Alpha-Melanocyte–stimulating Hormone Prevents Persistent Corneal Edema After Injury
Mass Eye and Ear/Mass General Ophthalmology
An international center for ophthalmology treatment and research, Mass Eye and Ear/Massachusetts General Hospital is the primary teaching hospital of Harvard Medical School’s Department of Ophthalmology, and is consistently recognized as one of the nation’s top hospitals for eye care. Led by Chief and Chair Joan W. Miller, MD, the department provides seamless access to the most innovative care available anywhere in the world.
